Naita M. Wirsik - Concepedia

Author

Naita M. Wirsik

Heidelberg University

Also Known As

N M Wirsik, N Wirsik, N. M. Wirsik, Naita M Wirsik, Naita M. Wirsik, Naita Maren Wirsik, Naita Wirsik

Publications

Citations

H-Index

Concepts

All Affiliations

Heidelberg University University Hospital Heidelberg Hertie Institute for Clinical Brain Research Goethe University Frankfurt University of Tübingen

About

Naita M. Wirsik is an author at Heidelberg University specializing in medicine, cytoskeleton, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	352
2	Health Sciences	1	1	333
3	Cell Biology	1	1	19
4	Cellular Physiology	1	1	19
5	Hepatology	1	1	333

Naita M. Wirsik

Publications

917

Citations

H-Index

Page 1

	Year	Citations
Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts Sonakshi Bhattacharjee, Florian Hamberger, Aashreya Ravichandra, Journal of Clinical Investigation	2021	338
Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer Ying Shen, Xiaohong Wang, Junyan Lu, Cancer Cell HepatologyGastrointestinal OncologyMedicineLiver PhysiologyLiver Metastasis Stiffness	2020	333
Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes Thomas Pausch, Elisa Aue, Naita M. Wirsik, Scientific Reports	2020	91
Community-driven development of a modified progression-free survival ratio for precision oncology Andreas Möck, Christoph E. Heilig, Simon Kreutzfeldt, ESMO Open	2019	40
Machine learning for optimized individual survival prediction in resectable upper gastrointestinal cancer Jin‐On Jung, Nerma Crnovrsanin, Naita M. Wirsik, Journal of Cancer Research and Clinical Oncology	2022	40
Viscumins functionally modulate cell motility-associated gene expression Sonja Schötterl, Miriam Hübner, Angela Armento, International Journal of Oncology Europe ExtractsChemoprevention StrategyImmunologyCytoskeletonCancer Biology	2017	19
Pericytes/vessel-associated mural cells (VAMCs) are the major source of key epithelial-mesenchymal transition (EMT) factors SLUG and TWIST in human glioma Lisa Mäder, Anna Eva Blank, David Capper, Oncotarget	2018	19
Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma<i>In Vitro</i>and<i>In Vivo</i>in Glioblastoma Bearing Mice Sonja Schötterl, Jennifer T. Miemietz, Elena I. Ilina, Evidence-based Complementary and Alternative Medicine	2019	15
TGF‐β activates pericytes via induction of the epithelial‐to‐mesenchymal transition protein SLUG in glioblastoma Naita M. Wirsik, J. Ehlers, Lisa Mäder, Neuropathology and Applied Neurobiology	2021	12
Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors Naita M. Wirsik, Thomas Schmidt, Henrik Nienhüser, Annals of Surgery	2023	10

Page 1